Mylan Pharmaceuticals Inc. made a hefty investment to improve Agila Specialties Pvt. Ltd. after its 2013 acquisition but despite the changes FDA has found numerous good manufacturing practice violations at three Agila plants in Bangalore, India.
On Aug